ALS Flashcards

1
Q

What does ALS stand for

A
  • Amyotrophic Lateral Sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generally describe ALS

A
  • aka Lou Gehrig’s disease
  • Severely progressive neurodegenerative disease that affects nerve cells in the brain & spinal cord
  • Adult onset type of progressive motor neuron disease
  • Both UMN (cortical neurons) and LMN (anterior horn cells) and axons can be affected
  • Damage/loss of motor neurons lead to profound muscle weakness
  • Cortical neuron impairments: cognitive function issues like attention deficits, language comprehension, & abstract reasoning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define ALS

A
  • Amyotrophy: no muscle nourishment/muscle wasting
  • Lateral sclerosis: gliotic scarring of lateral corticospinal tracts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Incidence/etiology of ALS

A
  • Rare condition
  • Onset around 40-60 yrs
  • 90% of cases are sporadic (cause unknown) and 5-10% being familial (FALS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors of ALS

A
  • Clusters have been reported in groups of people living/working in close proximity or participating in same sport
  • Chronic exposure to heavy metal: lead, mercury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hallmarks of ALS disease

A
  • Degeneration and loss of motor neurons, astrocytic gliosis, and microglial proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

UMN, LMN, and axon loss with ALS

A
  • UMN: in motor cortex/primary motor cortex, frontotemporal cortex, hippocampus, thalamus, & substantia nigra
  • LMN: in brainstem & spinal cord, loss of anterior horn cells through out spinal cord, specially in cervical, lumbar regions & bulbar pyramids
  • Axon loss with astrocytic gliosis in corticospinal & corticobulbar tracts (to non-oculomotor CNs 5, 7, 9, 10, 12)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What part is mostly spared in ALS

A
  • Posterior horn cells & columns are mostly spared
  • So sensation iis preserved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe pathogenesis of ALS

A
  • Genetic abnormalities in neurons: RNA content is reduced in damaged cells
  • Excessive production of reactive O2 species is also responsible for cell death
  • Disruption in axonal transport: spheroids found in axon & dendrites
  • Excitotoxic damage to cells from increased presence of glutamate
  • Selectivity in types of motor neurons affected: oculomotor neurons are spared
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe limb onset and bulbar onset

A
  • Limb: cortical & spinal motor neurons are affected 1st; limb muscles are affected (70% cases)
  • Bulbar: motor neurons of brainstem are affected 1st; muscles of throat, mouth, face are affected (25% cases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can initial clinical presentation vary

A
  • Trouble grasping a pen/lifting a coffee cup (loss of pincer grip due to split hand sign)
  • Tripping/falls
  • Muscle cramps/twitches
  • Change in vocal pitch when speaking
  • Uncontrollable periods of laughing or crying (pseudo-bulbar sign)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do patterns of muscle involvement/progression vary

A
  • Asymmetric progressing to symmetric weakness progressing from distal to proximal
  • Progressive muscle wasting (atrophy)
  • Extensors become weaker than flexors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical manifestations of ALS

A
  • Cervical extensor weakness causes drooping of the head (forward) with compensatory increase in lumbar lordosis to extend the neck
  • Weakness is followed by deformities in extensor muscles
  • Sensory functions, eye movements, bladder & bowel functions are mostly preserved
  • Cognitive impairment in 50% of cases: memory, attention, problem solving
  • Respiratory muscles affected in later stages: accessory breathing and respiratory distress can occur at night
  • Bulbar onset is more predictive of cognitive deficits than limb onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe UMN signs and LMN signs of ALS

A
  • LMN: cramping, muscle fasciculations, weakness, muscle wasting (atrophy)
  • UNM in limbs: spasticity, postive Babinski, exaggerated reflexes, clonus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bulbar signs and Pseudobulbar signs of ALS

A
  • Bulbar (LMN): dysarthria, hoarse & whispering voice, nasal tone, difficult swallowing, drooling, choking, facial & tongue muscle weakness/low tone (difficulty manipulating food in mouth)
  • Pseudobulbar (UMN): aka pseudobulbar palsy; corticobulbar tracts to brainstem are affected = slurred speech, difficulty chewing/swallowing, spastic tongue, uncontrolled emotional outbursts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Progressive spinal muscular atrophy (PMA) and primary lateral sclerosis (PLS) types of motor neuron diseases

A
  • PMA: only LMN affected, anterior horn cells of spinal cord affected beginning with cervical area, weakness/wasting of muscles, fasciculations present, can later turn into ALS
  • PLS: rarest type of motor neuron disease, only UMN affected, corticospinal tract involvement, spastic presentation, weakness, increased reflexes, no muscle atrophy, no fasciculations, outcome is less severe compared to ALS (people usually don’t die), can later turn into ALS
17
Q

Medical management/diagnosis of ALS using MRI

A
  • MRIs don’t show a lot but could show early markers: bilateral symmetrical hyper intensity along corticospinal tract forming a wine glass appearance
  • MRI of spinal cord can show symmetrical snake eye like signals in anterior horns
18
Q

How to diagnose ALS

A
  • Diagnose by clinical presentation, EMG, NCV tests, and MRI
  • EMG criteria for ALS: fibrillation, positive waveforms, fasciculations, polyphasic motor unit potentials in at least 3 limbs & paraspinal muscles
19
Q

How to differentially diagnose ALS

A
  • Need to rule out other similar looking conditions through urine, blood tests, and spinal CSF tap
  • Disorders in cervical cord must be ruled out: mostly do not involve lower limbs and can be confirmed be cervical cord imaging & EMG
  • Carcinoma will accompany weight loss, involvement of sensory system would suggest other neurodegenerative diseases
20
Q

What disorders can mimic ALS

A
  • Myasthenia gravis
  • Cervical myelopathy
  • Multifocal motor neuropathy
  • Hypoparathyroidism
  • Inclusion body myositis
  • Bulbospinal neuropathy
  • Lymphoma
  • Radiation induced affects
21
Q

Treatment of ALS

A
  • Riluzole and Edaravone are the only 2 FDA approved drugs: can slow disease progression but not curative
  • Antioxidants: Coenzyme Q10, vitamin E
  • Although no meds can stop the disease much can be done in the form of symptomatic therapy
22
Q

Physical therapy interventions to help treat ALS patients

A
  • Spasticity: movement to inhibit tone
  • Thick phlegm: insufflation/exsufflation
  • Joint pains: ROM exercise and warmth generating modalities
23
Q

Treatment during advanced stages of ALS

A
  • Assisting with feeding & breathing/coughing become important
  • Can modify consistency of food & fluids (by SLP) when maintaining nutrition becomes difficult
  • When mouth feeding is no longer possible & aspiration risk increases use a PEG tube
  • Breathing exercises as indicated: non-invasive ventilation (NIV), manual airway clearance followed by invasive ventilation
  • Which advanced progression the goal is to provide comfort and address end-of-life wishes
  • With focused care 80% can die at home
24
Q

Prognosis of ALS

A
  • Relentlessly progressive
  • Death occurs within 3-5 yrs resulting mainly from pneumonia caused by respiratory failure & poor nutrition
25
Q

Implications for PT

A
  • Staging of ALS helps decide appropriate interventions
  • OM ALS functional rating score - revised (ALSFRS-R) can be used to determine stage of ALS & to document progression
  • Tx can include: exercise programs in moderation to avoid fatigue; spasticity management (carful stretching); maintain of ROM to reduce contractures; functional mobility training as tolerated; thermal/TENS for pain management; home assessment, family/caregiver education for ongoing care; respiratory care from early to late stages
  • With disease progression: positioning, requirement of w/c, additional braces/supports for head/trunk control/shoulder subluxation
26
Q

Guidelines for treatment interventions depending on the ALS stages 1-2

A
  • Stage 1: ambulatory, independent in ADLs, begin ROM exercises, add strengthening program of gentle resistance exercises
  • Stage 2: slightly decreased independence in ADLs such as = difficulty climbing stairs, raising arms, & buttoning clothing; ambulatory, continue cautious strengthening, consider orthotic support, use AD to facilitate ADLs
27
Q

Guidelines for treatment interventions depending on the ALS stages 3-4

A
  • Stage 3: mod decreased independence in ADLs, easily fatiguable with long distance ambulation, keep pt physically independent as long as possible, encourage deep breathing exercises, chest stretching, & postural drainage if needed
  • Stage 4: wheelchair dependent, severe LE weakness, able to perform ADLs but fatigues easily, AAPROM, encourage isometric contractions, try arm slings, overhead slings, or wheelchair arm supports
28
Q

Guidelines for treatment interventions depending on the ALS stages 5-6

A
  • Stage 5: wheelchair dependent, increasingly dependent in ADLs, possible skin breakdown as a result of poor mobility, encourage family to learn proper transfer/positioning/turning techniques, encourage modifications at home
  • Stage 6: bedridden, completely dependent in ADLs, dysphagia = soft diet, long spoons, tube feeding, percutaneous gastrostomy; breathing difficulty = clear airway, tracheostomy, respirator if patient elects HMV